Intiva BioPharma Inc.·4

Nov 30, 1:08 PM ET

Wasoff Evan L 4

4 · Intiva BioPharma Inc. · Filed Nov 30, 2017

Insider Transaction Report

Form 4
Period: 2017-11-29
Wasoff Evan L
Chief Financial Officer
Transactions
  • Other

    Common Stock

    2017-11-29+629,1281,000,000 total
Footnotes (2)
  • [F1]As adjusted to reflect a one-for-six reverse split of the issuer's common stock effective November 29, 2017
  • [F2]Acquired in exchange for all of Evan Wasoff's shares of Intiva BioPharma Inc.

Documents

1 file
  • 4
    marketforms-40365.xmlPrimary

    PRIMARY DOCUMENT